Back to Results
First PageMeta Content
Health / Sexually transmitted diseases and infections / HIV/AIDS / Herpes / CAPRISA 004 / Gilead Sciences / Tenofovir / HIV / Microbicides for sexually transmitted diseases / Medicine / Microbiology / Microbicides


FACTS 001 QA 2.9.14_MB MS LC KA.docx.docx
Add to Reading List

Document Date: 2015-02-24 14:32:35


Open Document

File Size: 573,10 KB

Share Result on Facebook

City

Seattle / Natal / /

Company

HIV / Gilead Sciences / ITT / /

Country

Puerto Rico / Thailand / United States / South Africa / Peru / /

Facility

HIV Institute / US National Institute of Allergy / /

IndustryTerm

anti-retroviral-based prevention tools / treatment services / microbicide product / placebo / HIV prevention / family planning services / /

MedicalCondition

HIV infection / Opportunistic Infections / HSV (herpes) infections / HIV infections / AIDS / infection / infections / /

MedicalTreatment

antiretroviral therapy / counseling / /

Organization

Melinda Gates Foundation / National Institute of Health / United States Agency for International Development / Food and Drug Administration / US National Institute of Allergy and Infectious Diseases / South African Department of Science and Technology / Wits Reproductive Health and HIV Institute in Johannesburg / Department of Health / South African Medicines Control Council / /

Position

U.S. President / /

ProvinceOrState

Washington / /

URL

http /

SocialTag